Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT07296952
- Status
- Recruiting
Conditions
- Diabetic Retinopathy (DR)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- PRONTO-EYE — BEHAVIORALThe PROgram for Non-emergency TranspOrtation (PRONTO) - EYE intervention is a rideshare transportation program designed for patients to get to and from their visits. The intervention includes the rideshare as well as a service blueprint of the offering and how all individuals in the health system interact with it.
Study Details
This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
Key Dates
- Start date
- Feb 3, 2026
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: PRONTO-EYE rideshare intervention offeredAll eligible patients are invited to participate in PRONTO-EYE, a rideshare transportation program designed to improve adherence to eye care visits among Medicaid patients with diabetic retinopathy. All eligible patients are included in this arm regardless of if they decide to use PRONTO-EYE or not.
Primary Outcome Measure
Number of patients that adhere to their scheduled ophthalmology visits [ Time Frame: Baseline up to 6 months ]
Central Contacts
- Angelica Scanzera, OD, MPH312-996-3937
- Bhavana Kolli, DHA312-996-7182
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UI Health | Chicago | Illinois | 60647 |
Find similar trials in Chicago, IL
By research site
Related Studies
- Assessment of AI Program 'DRISTi' as a Screening ToolRecruiting · Artelus AI · Oxford, North Carolina
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsPHASE4 · Enrolling By Invitation · Harrow Inc · Tyler, Texas
- Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma CenterRecruiting · University of California, San Francisco · San Francisco, California